Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8862567 | 1.00 | ALDH1A1 (0.56) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL19414604 | 1.00 | ALDH1A1 (0.56) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL20068418 | 0.94 | ALDH1A1 (0.52) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL6744563 | 0.94 | ALDH1A1 (0.52) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL13259842 | 0.94 | ALDH1A1 (0.52) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL23714878 | 0.94 | ALDH1A1 (0.52) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL2858875 | 0.91 | ALDH1A1 (0.68) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL3853531 | 0.91 | ALDH1A1 (0.68) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL23714860 | 0.91 | ALDH1A1 (0.68) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 | |
| SCHEMBL13990452 | 0.91 | ALDH1A1 (0.68) | ALDH1A1CYP2C19L3MBTL1TDP1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3325463-B1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2019-06-05 | — | — | EP | disclosed |
| WO-2017013420-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LIMITED (GB) | 2017-01-26 | — | — | WO | disclosed |
| CN-106336408-A | Naphthothioxanthene derivative and preparation method and application thereof | 长春海谱润斯科技有限公司 | 2017-01-18 | — | — | CN | disclosed |
| US-20140328764-A1 | Biocompatible Nanoparticles with Aggregation Induced Emission Characteristics as Fluorescent Bioprobes and Methods of Using the Same for In Vitro and In Vivo Imaging | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2014-11-06 | — | — | US | disclosed |
| US-20140328764-A1 | Biocompatible Nanoparticles with Aggregation Induced Emission Characteristics as Fluorescent Bioprobes and Methods of Using the Same for In Vitro and In Vivo Imaging | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2014-11-06 | — | — | US | disclosed |
| WO-2013029340-A9 | BIOCOMPATIBLE NANOPARTICLES WITH AGGREGATION INDUCED EMISSION CHARACTERISTICS AS FLUORESCENT BIOPROBES AND METHODS OF USING THE SAME FOR IN VITRO AND IN VIVO IMAGING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2013-07-11 | — | — | WO | disclosed |
| WO-2013029340-A1 | BIOCOMPATIBLE NANOPARTICLES WITH AGGREGATION INDUCED EMISSION CHARACTERISTICS AS FLUORESCENT BIOPROBES AND METHODS OF USING THE SAME FOR IN VITRO AND IN VIVO IMAGING | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2013-03-07 | — | — | WO | disclosed |
| US-20120024382-A1 | NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES | THE UNIVERSITY OF ULM (DE) | 2012-02-02 | — | — | US | disclosed |
| EP-2379476-A1 | NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES | The University of Melbourne (AU) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010060160-A1 | NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES | THE UNIVERSITY OF MELBOURNE (AU) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010060159-A1 | NOVEL BLOCK COPOLYMERS, METHODS OF PREPARATION AND THEIR USE IN HETEROJUNCTION DEVICES | THE UNIVERSITY OF MELBOURNE (AU) | 2010-06-03 | — | — | WO | disclosed |
| US-5830972-A | PHOTOCONDUCTOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120024382-A1 | NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES | DDT, DCX, PIN1 | ALDH1A1 1940/4885CYP2C19 373/4885L3MBTL1 4517/4885 |
| US-20140328764-A1 | Biocompatible Nanoparticles with Aggregation Induced Emission Characteristics as Fluorescent Bioprobes and Methods of Using the Same for In Vitro and In Vivo Imaging | LGALS3, LGALS1, CD63 | ALDH1A1 731/4885CYP2C19 4676/4885L3MBTL1 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.